| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| SHR-9146 | HTI-1090; SHR-9146 | Phase 1 Clinical | Solid tumours; Neoplasms | Details | |
| LPM-3480226 | LY-01013; LPM-3480226 | Phase 1 Clinical | Luye Pharma Group Ltd | Solid tumours | Details |
| DN-1406131 | DN-131; DN-1406131 | Phase 1 Clinical | Jiangxi Qingfeng Pharmaceutical Industry Co Ltd, Shanghai De Novo Pharmatech Co Ltd | Solid tumours; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |